Related Experiment Video
Updated: Mar 11, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
Pathophysiological Mechanisms and Correlates of Therapeutic Pharmacological Interventions in Essential Arterial
Francesco Maranta1, Roberto Spoladore1, Gabriele Fragasso2
1Clinical Cardiology, Heart Failure Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Insights
Treating arterial hypertension requires managing comorbidities. Antihypertensive drugs should address blood pressure and improve metabolic conditions like diabetes and lipid disorders.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Arterial hypertension (HT) management is complex due to frequent comorbidities and metabolic abnormalities in patients.
- Choosing antihypertensive medications necessitates considering their impact beyond blood pressure, including effects on metabolic health.
Purpose of the Study:
- To review pathophysiological mechanisms in essential HT.
- To analyze pharmacological interventions for HT, focusing on comorbid conditions.
Main Methods:
- Literature review of pathophysiological mechanisms in essential HT.
- Analysis of therapeutic pharmacological interventions and their ancillary effects.
Main Results:
- Hypertensive patients often present with glucose intolerance, lipid disorders, atherosclerosis, and endothelial dysfunction.
- Drug selection must avoid negative interference with these conditions and ideally offer improvement.
Conclusions:
- Effective HT treatment involves addressing underlying pathophysiological mechanisms and comorbidities.
- Pharmacological choices should prioritize agents that positively impact metabolic and vascular health in hypertensive patients.
Abstract:
Treating arterial hypertension (HT) remains a hard task. The hypertensive patient is often a subject with several comorbidities and metabolic abnormalities. Clinicians everyday have to choose the right drug for the single patient among the different classes of antihypertensives. Apart from lowering blood pressure, a main therapeutic target should be that of counteracting all the possible pathophysiological mechanisms involved in HT itself and in existing/potential comorbidities. All the ancillary positive and negative effects of the administered drugs should be considered: in particular, since hypertensive patients are often glucose intolerant/diabetic, carrier of serum lipids disorder, have already developed atherosclerotic diseases and endothelial dysfunction, they should not be treated with drugs negatively interfering with these conditions but with molecules that, if possible, improve them. The main pathophysiological mechanisms and correlates of therapeutic pharmacological interventions in essential HT are reviewed here.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Atherosclerosis III: Management
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...

